Wolfe Research has downgraded its stock rating for HubSpot, citing concerns over the company's weaker growth prospects.

Wolfe Research has upgraded AT&T, citing improving fundamentals that are outweighing competitive risks for the telecommunications giant.

Wolfe Research suggests that Meta's potential expansion into AI cloud services could significantly increase its earnings.

Wolfe Research has identified a list of stocks that are at risk of lowering or eliminating their dividend payouts to shareholders, prompting a warning for investors.

Chevron's stock received an upgrade from Wolfe Research, citing a strong cash flow outlook for the energy giant.

Wolfe Research has turned bullish on Target, citing improvements in the retailer's operational execution as a key factor.

Wolfe Research has issued an Underperform rating for Avantor (AVTR), indicating a cautious outlook on the company's stock performance.

Wolfe Research predicts that market leadership will remain concentrated through 2026, indicating a continued focus on a limited number of dominant companies or sectors.

Micron's stock has surged by 223% this year, with Wolfe Research indicating further upside potential, prompting questions about whether this represents a brilliant setup or a recipe for disaster.

Wolfe Research has downgraded its rating for Boston Scientific Corporation (BSX) to 'Peer Perform' from its previous assessment.

Wolfe Research maintains a bullish outlook on Eli Lilly and Company, citing strong prospects for its pipeline of obesity drugs and potential market growth.

Wolfe Research has identified DoorDash (DASH) as one of its top stock picks. This recommendation highlights the firm's positive outlook on the food delivery company.

Wolfe Research reports that ongoing uncertainty surrounding COVID-19 continues to negatively impact the financial outlook for pharmaceutical giant Pfizer (PFE).

Wolfe Research has reduced its price target for ServiceNow (NOW) stock.

According to Wolfe Research, the adoption of artificial intelligence is growing, but its implementation remains primarily focused within specific industry sectors.

Wolfe Research has initiated coverage of BeOne Medicines AG (ONC) with an "Outperform" rating.

Following analysts' suggestions that Nvidia's $1 trillion orders guidance is a floor, not a ceiling, market sentiment indicates that the company's rally is expected to continue with significant future growth.

Wolfe Research has downgraded Starbucks to a neutral rating, citing an increasingly competitive coffee market.

Wolfe Research has identified several stocks with consistent dividend payments and solid track records, suggesting they could become dividend aristocrats amidst market volatility.

Wolfe Research has increased its stock price target for Remitly, citing margin expansion as the primary reason for the adjustment.

Wolfe Research has expressed wariness regarding Pentair plc, despite its status as a top UK dividend growth stock, raising questions about its future performance.

Wolfe Research has maintained its 'Outperform' rating on CoreWeave, signaling a positive outlook for the company's stock performance.

A battered oil major has received a 'buy' recommendation from Wolfe Research, indicating potential for recovery in its stock.

Wolfe Research has identified Palantir Technologies (PLTR) as a leader in enterprise AI, despite its premium valuation, according to a recent report.

Wolfe Research suggests investors play defense with dividend-paying companies that have a consistent 10-year track record of repurchasing their own shares.

Wolfe Research has begun its coverage of Super Micro Computer (SMCI) stock, providing initial analysis and recommendations for investors.

Wolfe Research has increased its price target for Micron Technology (MU) stock.

Wolfe Research has downgraded Danaher Corporation (DHR), indicating a revised outlook on the company's stock performance.

Wolfe Research has begun coverage of Tyra Biosciences, Inc. (TYRA) with a 'Peer Perform' rating.

Wolfe Research has shifted to a more defensive position on risk assets, citing increasing yield pressures in the market. This strategic adjustment reflects concerns over current economic conditions.

Wolfe Research has reiterated its focus on Nvidia's leading position in artificial intelligence, emphasizing the company's continued dominance in the sector.

Wolfe Research suggests that the market's reaction to Eli Lilly's (LLY) Foundayo report appears to be excessive, indicating a potential overcorrection in the stock price.

Wolfe Research has reportedly lifted its price target for Moody's (MCO) stock, indicating a positive outlook for the company's shares.

Wolfe Research has expressed a bullish outlook on The Home Depot, Inc. (HD), even amidst a general market downturn.

Wolfe Research has reiterated its "Buy" rating for Nvidia (NVDA), signaling continued confidence in the technology company's stock performance.

Fastenal (FAST) has been included in Wolfe Research's favorites list, identified as a key play in the ongoing manufacturing recovery.

Wolfe Research has increased its price target for Amazon, attributing the positive outlook to the strong performance of its AWS business, particularly from investments in AI and data centers.

Off-price retailers, such as Dollar General, are anticipated to be most severely affected by a projected surge in gasoline prices, according to Wolfe Research, which could impact consumer spending habits.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Wolfe Research has reiterated its 'Outperform' rating for RTX Corp following the company's deal with the Pentagon for a missile manufacturing framework.

Wolfe Research suggests investing in durable stocks that have reported better-than-expected earnings, as the stock market navigates choppy waters in July, making fundamentally strong companies more appealing.

Wolfe Research has begun its coverage of Solaris Energy (SEI).

Wolfe Research has downgraded Simon Property Group (SPG) stock, explaining the rationale behind the revised rating.

Wolfe Research has upgraded Kimco Realty (KIM) due to its strong fundamentals and reduced refinancing risk. This positive assessment reflects confidence in the company's financial health and market position.

Wolfe Research has reiterated its bullish stance on Arista Networks (ANET), setting a price target of $175 for the stock.

Palantir is in focus after Wolfe Research issued a 'Peer Perform' rating, drawing attention to the company's opportunities in artificial intelligence.

Wolfe Research highlights SpaceX's 'out-of-this-world' valuation, attributing it to the company's near-monopoly in the rocket launch business.

Wolfe Research has issued a report weighing in on the stock performance of West Pharmaceutical Services Inc (WST).

Wolfe Research has reaffirmed its 'Outperform' rating on Amazon (AMZN), noting the potential for significant growth in the company's supply chain operations.

Wolfe Research forecasts that the market for CPUs will expand by 30% through 2028, driven by the increasing demand from artificial intelligence workloads.

Wolfe Research has screened for companies with market capitalizations exceeding $250 million that also rank in the top quintile for their net cash-to-market cap ratio, indicating strong financial health.

Wolfe Research has issued a warning about potential risks posed by central bank policies, particularly as oil prices continue to remain elevated. The analysis suggests a complex interplay between monetary policy and commodity markets.

Wolfe Research maintains a 'buy' rating on Five Below, setting a $291 price target and suggesting a potential 26% surge in shares, partly due to the company's focus on popular products.

Wolfe Research suggests that companies with a consistent history of buying back their own stock can provide investors with a strategic advantage during volatile market periods.

Wolfe Research has upgraded its rating for Brinker International (EAT), the parent company of Chili's and Maggiano's Little Italy, to 'Outperform'.

Wolfe Research has highlighted its preferred dividend stocks, noting that market volatility has boosted their appeal, and provided a list of buy ideas.

Wolfe Research has noted conviction-driven opportunities within ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains, suggesting potential for growth.

Wolfe Research has adopted a bearish stance on Circle Internet Group (CRCL), citing lower EBITDA expectations.